WALL STREET RESEARCHER
We have recently published the following Research Reports:
This tele-health company,specializing in type II diabetes, is expanding rapidly , acquiring new members at a record rate.The company projects $96 Million in revenues and $52 million in profits by fiscal 2025. We feel these shares have significant upside potential .
This company produces organic wines distributing to major national retailers including Walmart, Whole Foods, Albertsons, HEB, Central Market, and HyVee, In addition the company distributes on- line to retail buyers of fine wines. A recent $22 Million IPO has provided expansion and advertising funding .
A life sciences company producing medical lab equipment .The company produces three pressure based platforms, all of which are patented. One of those is the Ultra Shear Technology, the other is Pressure Cycling Technology and the third is the Bare Fold Platform..
Biotech company working closely with Youngstown State University and Arizona State University develop safe and successful treatments for such diseases as . Alzheimers, PTSD, and Chronic Traumatic Encephalopathy. Halberd proposes treatments that include the cleansing bodily fluids through extracorporeal lasar methodolgy..
This oil sevice waste water disposal – cleaning and remediation company has recently advanced on strong Q4 earnings with nine month revs up 81% . Total assets have doubled over the past three years to over $73 million .
This company is a Bitcoin miner . Using an array of state of the art high speed computers , this company operates at the leading edge of technology . In addition to mining Bitcoin, this company sells its S19j Pro high speed computer array along with offering hosting services to other miners.
Neither PSN or WSR nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN or WSR website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN or WSR website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN or WSR website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision. Writer charges a fee of $7500 per Resaearch Report. All Research Reports are reviewed by company mamagement for accuracy and concur that any conclusions made are reasonable expectations. The term Buy List referring to a Watch List and not a recommendation to buy . Each individual has their own risk level and should know their risk level and act accordingly